By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nucleic acids provider Integrated DNA Technologies said today that it has received a Phase II Small Business Innovation Research grant to continue developing a gene silencing technology project it is developing with a start-up firm called SilaGene.

The new technology uses U1 adapters to down-regulate gene expression at the pre-mRNA stage, which could be used as a method of gene silencing in potential therapeutic technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.